Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Kalbe Farma Tbk PT banner

Kalbe Farma Tbk PT
SWB:LCLA

Watchlist Manager
Kalbe Farma Tbk PT Logo
Kalbe Farma Tbk PT
SWB:LCLA
Watchlist
Price: 0.0295 EUR -29.76% Market Closed
Market Cap: €1.4B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...

Wall St Price Targets

LCLA Price Targets Summary
Kalbe Farma Tbk PT

Wall Street analysts forecast LCLA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LCLA is 0.0676 EUR with a low forecast of 0.045 EUR and a high forecast of 0.0925 EUR.

LCLA Lowest Forecast
0.045 EUR
53% Upside
LCLA Average Forecast
0.0676 EUR
129% Upside
LCLA Highest Forecast
0.0925 EUR
214% Upside
Lowest Forecast
Price Target
0.045 EUR
53% Upside
Average Forecast
Price Target
0.0676 EUR
129% Upside
Highest Forecast
Price Target
0.0925 EUR
214% Upside
Kalbe Farma Tbk PT Competitors:
Price Targets

Revenue
Forecast

8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Revenue Forecast
is not available for Kalbe Farma Tbk PT

Gross Profit
Forecast

6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Kalbe Farma Tbk PT

Operating Income
Forecast

6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Kalbe Farma Tbk PT

Pre-Tax Income
Forecast

6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Kalbe Farma Tbk PT

Net Income
Forecast

6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for Kalbe Farma Tbk PT

See Also

Summary
LCLA intrinsic value, competitors valuation, and company profile.
DCF Valuation
LCLA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LCLA stock valuation using valuation multiples.
Wall St Estimates
LCLA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LCLA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Kalbe Farma Tbk PT listings:
OTC • USD
PTKFF
 OTC • USD
PTKFY
 F • EUR
LCLA
 XBER • EUR
LCLA
 IDX • IDR
KLBF
 XMUN • EUR
LCLA
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is LCLA's stock price target?
Price Target
0.0676 EUR

According to Wall Street analysts, the average 1-year price target for LCLA is 0.0676 EUR with a low forecast of 0.045 EUR and a high forecast of 0.0925 EUR.

Back to Top
ALPHA SPREAD
Follow us
Join 343,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett